FDA Investigator Frances M Rivera
Frances M Rivera has inspections in 1 countries as of 16 Oct 2023. Frances M Rivera has collaborated with a combined 952 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
45
Last Inspection Date:
16 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Aaron J Fox,
Alexander B Anderson,
Anabel Veiga,
Andrea Dcharles Julien,
Angela E Glenn,
Angela F Orozco,
Brian M Carril,
Bruce Quijano,
Carla A Norris,
Carol S Davis,
CDR Sean T Creighton,
Chyla T Hunter,
Clara E Santiago,
David P King,
Dawne M Hines,
Diana L Kelsch,
Edwards,
Eric R Holm,
Ethan P Stegman,
Frances M Rivera Rosario,
Gabriel E Muniz,
Gina Eng,
Hunt,
James To Neal,
Jennifer L Huntington,
Jennifer M Menendez,
John J Bernal,
Karissa J Mccaw,
Karl D Hezel,
Leslin M Coachman,
Linda K Matheny,
Lisa A Warner,
LT Prince D Brown,
LT Tamara J Henderson,
Marc Balzarini,
Marinee Flores Marrero,
Mary F Bodick,
Megan K Otero,
Melinda B Lewis,
Mendoza,
Michael C Lombardi,
Neimar Lopez Martinez,
Ormond,
Paul A Licata,
Paul H Dakin,
Raymond A Lyn, Jr,
Reynolds,
Ronan F King,
Scott R Izyk,
Sharon Giamberini,
Shavon L Square,
Sheri L Stephenson,
State Agency,
Suzanne A Lovelady,
Teresa I Navas,
Toby L Keaton,
William A Oetting,
Yazmith Guzman
Frances M Rivera's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2018 | EIR | OXYGEN DEVELOPMENT, L.L.C. - EIR, 2018-01-19 |
January, 2018 | FDA 483 Response | OXYGEN DEVELOPMENT, L.L.C. - Form 483R, 2018-02-01 |
January, 2018 | FDA 483 | OXYGEN DEVELOPMENT, L.L.C. - Form 483, 2018-01-17 |
January, 2018 | EIR | OXYGEN DEVELOPMENT, L.L.C. - EIR, 2018-01-17 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more